Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Filgrastim × Other solid neoplasm × Clear all

Phase

Phase 1 12 Phase 2 10 Phase 3 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 19 Other hematologic neoplasm 17 Myeloid 8 Plasma cell 7 Dermatologic 6 Sarcoma 5 Classical hematology 3 CNS 2 Breast 2 Other solid neoplasm 1 Head & Neck 1 Genitourinary 1

Conditions

Retinoblastoma 1

Interventions

Early Intervention, Educational 26 Interviews as Topic 21 Educational Status 18 Methods 17 Practice Guidelines as Topic 15 Standard of Care 14 Counseling 7 Specimen Handling 6 Health Promotion 6 Psychiatric Rehabilitation 5 Proton Therapy 5 Palliative Care 5 Fluorodeoxyglucose F18 5 Carboplatin 5 Behavior Therapy 5 Drug Therapy 4 Cryotherapy 4 Telemedicine 3 Restraint, Physical 3 Radiotherapy 3 Patient Navigation 3 Paclitaxel 3 Nutrition Assessment 3 Mindfulness-Based Stress Reduction 3 Mindfulness 3 Melphalan 3 Exercise Test 3 Blood Specimen Collection 3 Acupressure 3 pazopanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00980551 2017-03-03

RELRB1

Children's Hospital Medical Center, Cincinnati

Phase NA Withdrawn

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡